🎗️ OncologyInjection (IV)
Elahere
Mirvetuximab Soravtansine
Folate receptor alpha-directed antibody-drug conjugate for FRα-positive platinum-resistant ovarian cancer.
Form
Injection (IV)
Uses
1
Side effects
5
Category
Oncology
01
What is Elahere used for?
- Platinum-resistant ovarian cancer (FRα-positive)
02
Mirvetuximab Soravtansine side effects
The following side effects have been reported for Mirvetuximab Soravtansine. Their order does not indicate how often an effect occurs.
Ocular toxicity
Peripheral neuropathy
Nausea
Fatigue
Diarrhea
03
Mirvetuximab Soravtansine warnings & precautions
- Ocular toxicity. Premedication and ophthalmic monitoring required
- Embryo-fetal toxicity
- Peripheral neuropathy
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Elahere in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.